AHL Partners’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
$10.9M Buy
79,810
+13,512
+20% +$1.79M 0.17% 182
2017
Q3
$8.6M Sell
66,298
-42,842
-39% -$5.71M 0.15% 220
2017
Q2
$14.5M Buy
109,140
+9,265
+9% +$1.13M 0.31% 34
2017
Q1
$12.3M Buy
99,875
+82,602
+478% +$9.78M 0.27% 45
2016
Q4
$1.91M Sell
17,273
-11,340
-40% -$1.26M 0.06% 523
2016
Q3
$3.38M Sell
28,613
-15,551
-35% -$1.83M 0.13% 247
2016
Q2
$4.94M Buy
+44,164
New +$4.75M 0.27% 84
2015
Q2
Sell
-25,905
Closed -$2.81M 855
2015
Q1
$2.81M Sell
25,905
-31,193
-55% -$3.21M 0.11% 435
2014
Q4
$5.29M Sell
57,098
-68
-0.1% -$6.01K 0.27% 45
2014
Q3
$5M Buy
+57,166
New +$5.17M 0.39% 58

Other funds holding LH

AHL Partners's LH Position: Q4 2017 in Review

AHL Partners increased its Labcorp (LH) stake by 20% in Q4 2017, buying an estimated $1.79M and bringing the position to 79,810 shares worth $10.9M. The position accounts for 0.17% of the portfolio, ranked #182.

AHL Partners first reported a position in LH in Q3 2014 and has held it in 10 quarters since. The position peaked at $14.5M in Q2 2017. 753 funds tracked by Wall St. Rank hold LH as of Q4 2017.

  • AHL Partners held 79,810 shares of Labcorp worth $10.9M as of Q4 2017.
  • AHL Partners bought 13,512 Labcorp shares in Q4 2017, an estimated $1.79M.
  • Labcorp made up 0.17% of AHL Partners's portfolio in Q4 2017, its #182 holding.
  • AHL Partners first reported a position in Labcorp in Q3 2014 and has held it in 10 quarters since.
  • AHL Partners's Labcorp position peaked at $14.5M in Q2 2017.
  • 753 funds tracked by Wall St. Rank held Labcorp as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.